Saving the zone of stasis in burns with activated protein C: An experimental study in rats

Burns

Volumn 36, Issue 3, 2010, Pages 397-402

  Nisanci, Mustafa ^a   Eski, Muhitdin ^a   Sahin, Ismail ^a   Ilgan, Seyfettin ^a   Isik, Selcuk ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Activated protein C; Burn injury; Saving the zone of stasis

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; PROTEIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BURN; CONTROLLED STUDY; DRUG EFFECT; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; RAT; SKIN NECROSIS; TISSUE PERFUSION; ANIMAL; BLOOD FLOW; BURNS; DISEASE MODEL; DRUG EFFECTS; DRUG SCREENING; NECROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; SKIN; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; ANTICOAGULANTS; AUTORADIOGRAPHY; BURNS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; LASER-DOPPLER FLOWMETRY; MALE; NECROSIS; PROTEIN C; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; SKIN;

EID: 77649339431     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2009.06.208     Document Type: Article

References (28)

1. Jackson D.M. The diagnosis of the depth of burning. Br J Surg 40 (1953) 588-596
2. Dziewulski P. Burn wound healing: James Ellsworth Laing memorial Essay for 1991. Burns 18 6 (1992) 466-478
3. Boykin J.V., Eriksson E., and Pittman R.N. In vivo microcirculation of scald burn and the progression of postburn dermal ischaemia. Plast Reconstr Surg 66 (1980) 191-198
4. Arturson G. Pathophysiology of the burn wound and pharmacological treatment: the Rudi Hermans Lecture. Burns 22 (1996) 255-274
5. Kufman T., Neuman R.A., and Weinberg A. Is postburn dermal ischemia enhanced by oxygen free radicals?. Burns 15 (1989) 291-294
6. Isik S S., Kopal C., Karacali{dotless}oglu O., and Selmanpakoglu N. The effect of the delay phenomenon on the zone of stasis in burns: experimental study in rabbits. Ann Burns Fire Disasters 13 (2000) 101-106
7. Isik S., Sahin U., Ilgan S., Guler M., Gunalp B., and Selmanpakoglu N. Saving the zone of stasis in burn with recombinant tissue-type plasminogen activator (r-tPA): an experimental study in rats. Burns 24 (1998) 217-223
8. Choi M., and Ehrlich H.P. U75412E: a lazaroid, prevents progressive burn ischemia in a rat burn model. Am J Pathol 142 2 (1993) 519-528
9. Zor F., Ozturk S., Deveci M., Karacalioglu O., and Sengezer M. Saving the zone of stasis: is glutathione effective?. Burns 31 (2005) 972-996
10. Regas F.C., and Ehrlich H.P. Elucidating the vascular response to burns with a new rat model. J Trauma 32 (1992) 557-563
11. Mizutani A., Okajima K., Uchiba M., and Noguchi T. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 95 12 (2000) 3781-3787
12. Taylor Jr. F.B., Chang A., Esmon C.T., D'Angelo A., Vigano- D'Angelo S., and Blick K.E. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 79 3 (1987) 918-925
13. Taylor Jr. F.B., Chang A.C., Peer G.T., Mather T., Blick K., Catlett R., et al. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. Blood 78 (1991) 364-368
14. Murakami K., Okajima K., Uchiba M., Johno M., Nakagaki T., Okabe H., et al. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 87 2 (1996) 642-647
15. Murakami K., Okajima K., Uchiba M., Johno M., Nakagaki T., Okabe H., et al. Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol 272 2Pt1 (1997) L197-202
16. Boyd G.A. In: Boyd G.A. (Ed). Autoradiography in Biology and Medicine (1955), Academic, New York
17. Mahajan A.L., Tenorio X., Pepper M.S., Baetens D., Montandon D., Schlaudraff K., et al. Progressive tissue injury in burns is reduced by rNAPc2. Burns 32 (2006) 957-963
18. Eski M., Deveci M., Celikoz B., Nisanci M., and Turegun M. Treatment with cerium nitrate bathing modulate systemic leukocyte activation following burn injury: an experimental study in rat cremaster muscle flap. Burns 27 (2001) 739-746
19. Chappell V.L., LaGrone L., and Mileski W.J. Inhibition of leukocyte- mediated tissue destruction by synthetic fibronectin peptide (Trp-9-Tyr). J Burn Care Rehabil 20 6 (1999) 505-510
20. Bucky L.P., Vedder N.B., Hong H.Z., Ehrlich H.P., Winn R.K., Harlan J.M., et al. Reduction of burn injury by inhibiting CD18-mediated leukocyte adherence in rabbits. Plast Reconstr Surg 93 7 (1994) 1473-1480
21. Mileski W.J., Burkhart D., Hunt J.L., Kagan R.J., Saffle J.R., Herndon D.N., et al. Clinical effect of inhibiting leukocyte adhesion with monoclonal antibody to intercellular adhesion molecule-1 (enlimomab) in the treatment of partial-thickness burn injury. J Trauma 54 5 (2003) 950-958
22. Walker F.J., Sexton P.W., and Esmon C.T. The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V. Biochim Biophys Acta 571 (1979) 333-339
23. Griffin J.H., Kojima K., Banka C.L., Curtiss L.K., and Fernández J.A. High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C. J Clin Invest 103 (1999) 219-227
24. Deveci M., Eski M., Sengezer M., and Ki{dotless}sa U. Effect of cerium nitrate bathing and prompt burn wound excision on IL-6 and TNF-Alfa levels in burned rat. Burns 26 (2000) 41-45
25. ®) for the treatment of severe sepsis in adults: a systematic review and economic evaluation. Health Technol Assess 9 11 (2005)
26. Russell J.A. Management of sepsis. N Engl J Med 355 October (16) (2006) 1699-1713
27. Bernard G.R., Vincent J.L., Laterre P.F., LaRosa S.P., Dhainaut J.F., Lopez-Rodriguez A., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 March (10) (2001) 699-709
28. Bernard G.R., Ely E.W., Wright T.J., Fraiz J., Stasek Jr. J.E., Russell J.A., et al. Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis. Crit Care Med 29 11 (2001) 2051-2059